October 14, 2022Diabetes Obesity and Metabolism15 citations

Sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real‐world clinical practice? A systematic review and meta‐analysis of observational studies

WHWilliam HintonUniversity of Oxford AAAbdus Samad AnsariMoorfields Eye Hospital NHS Foundation Trust MWMartin WhyteUniversity of Surrey

Key Points

Key points are not available for this paper at this time.

Abstract

Real-world SGLT2 inhibitor use supports randomized trial data for the size effect of reduced hospitalization for heart failure in type 2 diabetes, although with a much lower ARR in people without CVD.

AIに質問

Bookmark

View Full Paper

Cite This Study

Hinton et al. (Fri,) studied this question.

synapsesocial.com/papers/69dd4e682f737f012599ba13 https://doi.org/https://doi.org/10.1111/dom.14893

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AIに質問

Bookmark

View Full Paper